Sarah J. Schlesinger Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah J. Schlesinger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah J. Schlesinger. Sarah J. Schlesinger is Director in Armata Pharmaceuticals, Inc. ($APHB) and Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in Innoviva, Inc. ($THRX) and Director in MEDICINES CO /DE ($MDCO).
Latest Insider Trading Transactions of Sarah J. Schlesinger
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, APHB, THRX, MDCO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 09 2020 | APHB | Armata Pharmaceuti ... | Schlesinger Sarah J. | Director | Option Exercise | A | 3.15 | 23,000 | 72,450 | 23,000 | |
| Feb 14 2020 | APHB | Armata Pharmaceuti ... | Schlesinger Sarah J. | Director | Option Exercise | A | 4.17 | 27,383 | 114,187 | 27,383 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Option Exercise | D | 34.81 | 8,410 | 292,752 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Option Exercise | D | 33.86 | 9,141 | 309,514 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Option Exercise | D | 29.83 | 26,383 | 787,005 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Sell | D | 0.00 | 7,429 | 0 | 0 | 7.4 K to 0 (-100.00 %) |
| Jun 03 2019 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Option Exercise | A | 34.81 | 8,410 | 292,752 | 8,410 | |
| Jun 03 2019 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 3,663 | 0 | 7,429 | 3.8 K to 7.4 K (+97.27 %) |
| May 24 2019 | THRX | Innoviva, Inc. | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 16,399 | 0 | 41,165 | 24.8 K to 41.2 K (+66.22 %) |
| Jun 04 2018 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Option Exercise | A | 33.86 | 9,141 | 309,514 | 9,141 | |
| Jun 04 2018 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 3,766 | 0 | 3,766 | 0 to 3.8 K |
| Apr 26 2018 | THRX | Innoviva, Inc. | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 14,249 | 0 | 24,766 | 10.5 K to 24.8 K (+135.49 %) |
| Feb 26 2018 | MDCO | MEDICINES CO /DE | Schlesinger Sarah J. | Director | Option Exercise | A | 29.83 | 26,383 | 787,005 | 26,383 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | D | 4.91 | 25,000 | 122,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | D | 6.45 | 25,000 | 161,250 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | D | 7.39 | 25,000 | 184,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | D | 20.98 | 40,000 | 839,200 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Sell | D | 0.00 | 55,508 | 0 | 0 | 55.5 K to 0 (-100.00 %) |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Gift | G | 0.00 | 15,600 | 0 | 0 | 15.6 K to 0 (-100.00 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 23.82 | 25,000 | 595,500 | 25,000 | |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 55,508 | 43 K to 55.5 K (+29.06 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 5,508 | 0 | 43,008 | 37.5 K to 43 K (+14.69 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 12,500 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 25,000 | 12.5 K to 25 K (+100.00 %) |
| Jan 15 2015 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 6.25 | 1,300 | 8,125 | 15,600 | 14.3 K to 15.6 K (+9.09 %) |
| Jan 15 2015 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 6.97 | 1,300 | 9,061 | 14,300 | 13 K to 14.3 K (+10.00 %) |
| Dec 18 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 6.11 | 1,300 | 7,943 | 13,000 | 11.7 K to 13 K (+11.11 %) |
| Dec 18 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 6.07 | 1,300 | 7,891 | 11,700 | 10.4 K to 11.7 K (+12.50 %) |
| Nov 13 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 6.22 | 1,300 | 8,086 | 10,400 | 9.1 K to 10.4 K (+14.29 %) |
| Nov 13 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 6.30 | 1,300 | 8,190 | 9,100 | 7.8 K to 9.1 K (+16.67 %) |
| Oct 16 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 5.03 | 1,300 | 6,539 | 7,800 | 6.5 K to 7.8 K (+20.00 %) |
| Oct 16 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 5.07 | 1,300 | 6,591 | 6,500 | 5.2 K to 6.5 K (+25.00 %) |
| Sep 11 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 5.75 | 1,300 | 7,475 | 5,200 | 3.9 K to 5.2 K (+33.33 %) |
| Sep 11 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 5.93 | 1,300 | 7,709 | 3,900 | 2.6 K to 3.9 K (+50.00 %) |
| Sep 11 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 5.71 | 1,300 | 7,423 | 2,600 | 1.3 K to 2.6 K (+100.00 %) |
| Sep 11 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Buy | P | 5.52 | 1,300 | 7,176 | 1,300 | 0 to 1.3 K |
| Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
| Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jul 17 2013 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 20.98 | 40,000 | 839,200 | 40,000 |
Page: 1